IOBT
IO Biotech·NASDAQ
--
--(--)
--
--(--)
3.77 / 10
Netural
Sentiment is neutral (3.77/10) and fund‑flow score is strong at 7.54, driven by inflows in small and medium investors but outflows among large blocks. Analyst coverage is limited, with a single neutral rating, reinforcing a mixed but cautiously optimistic view.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-26
InstitutionPiper Sandler
Times predicted2
Historical Win Rate0.0%
What is the analyst consensus for IOBT?
- IOBT holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.77/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
